Mitsui, QSimulate, and Quantinuum Launch “QIDO”: A Quantum-Integrated Chemistry Platform Targeting Faster Drug and Materials Discovery

QIDO integrates high-performance quantum chemistry workflows and quantum computing to shorten ‘molecule-to-market’ timelines across the pharmaceutical, energy, and chemical sectors, and beyond

August 19, 2025

Tokyo, Japan, August 19th, 2025 — Mitsui & Co., Ltd. (“Mitsui”), QSimulate, and Quantinuum today announced the launch of a new quantum-integrated chemistry platform, QIDO (Quantum-Integrated Discovery Orchestrator). This platform aims to reduce the time and cost of developing new drugs and materials. QIDO accelerates research and development through high-precision chemical reaction modeling and seamlessly combines the advantages of cutting-edge classical computing and quantum computing.

Built for commercial impact, QIDO streamlines complex quantum-classical hybrid workflows and helps companies make decisions earlier in the development process, contributing to a powerful competitive advantage in innovation. The platform is designed to support research across an array of chemistry-based fields, including advanced materials design, clean energy, and drug development.

Proprietary Technology Supporting QIDO

QIDO seamlessly integrates QSimulate's software “QSP Reaction,” which enables calculations on the scale of thousands of atoms using the highest precision classical quantum chemistry methods and techniques. QIDO also integrates with Quantinuum's “InQuanto" software, which interfaces with state-of-the-art quantum emulators and world-leading Quantinuum Systems hardware. InQuanto™ achieves up to 10 times higher accuracy in simulations of complex molecules and materials compared to open-source software.

  • ‍Makoto Koshida, General Manager, Quantum Innovation Department, Mitsui: “We take a market-needs-based approach, aiming to bridge the gap between providing practical features that help customers solve today's challenges and preparing them for the coming quantum era. This approach enables customers to maximize its benefits from day one when quantum technology comes into its own.” ‍
  • Toru Shiozaki, Ph.D., President & CEO, QSimulate: “Combining best-in-class quantum chemical simulation with deep quantum computing expertise, QIDO gives industrial chemists powerful, intuitive algorithms and tools to tackle complex chemical challenges with speed and accuracy. We are excited about the marriage between years of innovation in quantum chemistry automation and the future of quantum computation.” ‍
  • Dr. Rajeeb Hazra, President & CEO, Quantinuum: “Adding the benefits of chemical accuracy and computational efficiency of quantum-native simulations in applications of chemistry is a key step forward in revolutionizing the economics of discovery in several significant end markets, such as pharmaceuticals and energy. Quantinuum is proud to offer the industry's highest-performing quantum computers and widely used quantum chemistry software to enable this progress.”
QIDO Use Cases and Future Expansion

QIDO is launched together with a high-precision chemical reaction analysis module based on the so-called active space approach. Potential use cases are as follows:‍

  • ‍Catalysts and enzyme design: Simulating complex electron behavior to inform high-efficiency catalysts and enzymes design for cleaner energy, greener manufacturing, and advanced biocatalysis (useful in drug discovery, food processing, biofuel, etc.). ‍
  • Reaction mechanism elucidation: Enabling deeper understanding of complex chemical reaction pathways, including transient intermediates and excited states, for material stability, performance, and lifetime improvements.‍
  • Battery efficiency and energy storage: Enhancing battery materials and performance for safer, longer-lasting, and higher-capacity energy storage.‍
  • Sustainable materials and energy: Advancing energy-efficient materials, improving carbon capture and reuse, and supporting green ammonia and hydrogen production.

QIDO will gradually add new features to accelerate innovation in high-impact use cases, such as battery innovation and drug development. Innovation in these fields through quantum technology will be realized through 'co-creation' with our customers.

Feedback from Industry Leaders

As QIDO's exclusive distributor in Japan and a strategic partner with an eye toward future “co-creation,” Mitsui & Co. is leading domestic sales and distribution, laying the foundation for future global expansion. Prior to the general release of QIDO in the Japanese market, Mitsui & Co. conducted beta testing with three industry-leading companies.

  • ‍JSR Corporation: “The platform provided by QSimulate lowers the barriers to computation by simplifying input, automating error handling, and focusing output on necessary information, making it an integral tool in the daily workflows of synthetic organic chemists at JSR. With this platform now extended to support quantum chemistry calculations on quantum computers via InQuanto, it offers a path to an early quantum advantage.” – Yu-ya Ohnishi, Ph.D., Research Fellow & Deputy Director, R&D Technology & Digital Transformation Center, Materials Informatics Promotion Office‍
  • Panasonic Holdings Corporation: “This platform provides users with a tool to intuitively perform chemical reaction simulations through a graphical user interface. In the anticipated era of large-scale fault-tolerant quantum computing, materials simulation is regarded as a promising application domain. Integrated with quantum computing, this platform is expected to offer opportunities for early-stage validation in preparation for future breakthroughs.” – Takahiro Ohgoe, Ph.D., Senior Lead Researcher, Green Innovation Center, Green Transformation Division‍
  • Chugai Pharmaceutical: “This application offers an intuitive interface that combines user-friendly operability with clear, instantly interpretable result visualization—making reaction pathway exploration easier and more efficient than ever. At present, we recognize several technical challenges in applying the system to complex molecular calculations encountered in drug discovery and pharmaceutical research. As these challenges are steadily addressed, we expect this application to play a meaningful role in accelerating and optimizing the synthesis and process development of candidate molecules with complex chemical structures—ultimately contributing to innovation in drug discovery and the advancement of pharmaceutical development.” – Akihiko Arakawa, Ph.D., Data Science Group, Digital Solution Dept., Digital Transformation Unit
Notable Functions of QIDO

QIDO is equipped with various functions to streamline high-precision chemical modeling. This makes quantum chemistry technology, which was previously only available to experts, more accessible for use in industrial settings.

  • Automatically identify reaction coordinates and transition states from specified reactants and products;
  • Map strongly correlated systems to compact Hamiltonians using quantum embedding and automated active space selection techniques;
  • Support customizable active spaces and computational methods to balance accuracy and cost;
  • Provides optimized energy calculations for reactants, products, and transition states using quantum hardware and their emulators;
  • Visualizes quantum circuits and reports the required quantum resources.

For purchases, trial applications, and other details, please visit: https://mitsui-q.com/en/qido/.

About Mitsui & Co., Ltd.

Mitsui & Co. is a global trading and investment company with a presence in more than 60 countries and a diverse business portfolio covering a wide range of industries.

The company identifies, develops, and grows its businesses in partnership with a global network of trusted partners including world leading companies, combining its geographic and cross-industry strengths to create long-term sustainable value for its stakeholders.

Mitsui has set three key strategic initiatives for its current Medium-term Management Plan: supporting industries to grow and evolve with stable supplies of resources and materials, and providing infrastructure; promoting a global transition to low-carbon and renewable energy; and empowering people to lead healthy lives through the delivery of quality healthcare and access to good nutrition.

For more information, please visit: https://www.mitsui.com/jp/en/index.html

About QSimulate

Founded in 2019 and headquartered in Boston, MA, QSimulate is a leader in quantum simulation technology for materials development and life sciences. The company offers a range of products and services designed to leverage the power of quantum mechanics to solve industrial-scale problems like never before.

For more information, please visit: https://qsimulate.com/

About Quantinuum

Quantinuum is the world leader in quantum computing. The company’s quantum systems deliver the highest performance across key industry benchmarks. Quantinuum’s over 550 employees, including 370+ scientists and engineers, across the US, UK, Germany, and Japan, are driving the quantum computing revolution.

For more information, please visit: https://www.quantinuum.com

About Quantinuum

Quantinuum, the world’s largest integrated quantum company, pioneers powerful quantum computers and advanced software solutions. Quantinuum’s technology drives breakthroughs in materials discovery, cybersecurity, and next-gen quantum AI. With over 500 employees, including 370+ scientists and engineers, Quantinuum leads the quantum computing revolution across continents. 

September 11, 2026
Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference

BROOMFIELD, Colo., September 11, 2026 - Quantinuum Inc. (Nasdaq: QNT) (the “Company”), a leading quantum computing company, today announced that members of its management team will participate in the Piper Sandler 5th Annual Growth Frontiers Conference, taking place September 14–16, 2026, in Nashville, Tennessee.

Quantinuum will participate in a fireside chat and host one-on-one meetings with investors during the conference.

About Quantinuum

Quantinuum is a leading quantum computing company offering a full-stack platform designed to make quantum computing deployable in real-world environments. The company has commercially deployed multiple generations of trapped-ion based quantum systems built on the well-established QCCD architecture, which it has implemented with novel designs and capabilities to achieve the industry’s highest accuracy levels based on average two-qubit gate fidelity. Quantinuum has active engagements with market leaders across pharmaceuticals, material science, financial services, and government and industrial markets, as well as academic and research institutions globally.

The company has a global workforce of approximately 800 employees, including top scientists and researchers. Over 70% of its technology team holds PhDs or Master’s degrees. Quantinuum’s headquarters is in Broomfield, Colorado, with additional facilities across the United States, United Kingdom, Germany, Japan, Qatar, and Singapore.

Contacts

Investor & Media Contact

Shub Mukherjee - Investor Contact - investors@quantinuum.com

Aaron Sorenson - Media Contact - press@quantinuum.com

This is some text inside of a div block.
All
This is some text inside of a div block.
All
This is some text inside of a div block.
All
September 8, 2026
Quantinuum Finalizes $100 Million CHIPS R&D Award with U.S. Department of Commerce to Advance Trapped-Ion Quantum Computer Manufacturing in the US
  • The federal funding supports critical R&D and U.S. quantum semiconductor manufacturing capabilities needed to scale fault-tolerant trapped-ion quantum computing.
  • Company partnering with GlobalFoundries to fabricate next-gen ion traps and control electronics, and Monarch Quantum to develop and manufacture reliable lasers and optical components.

Washington, D.C. – September 8, 2026 – Quantinuum (Nasdaq: QNT), a leading quantum computing company, today announced it has finalized an agreement with the U.S. Department of Commerce’s CHIPS Research and Development Office for $100 million in federal funding deployed through the CHIPS and Science Act. The award, which follows a letter of intent announced in May, supports R&D and U.S. quantum semiconductor manufacturing capabilities needed to deploy large-scale, fault-tolerant trapped-ion quantum computers.

Quantinuum, which was the only company with a trapped-ion based architecture to be awarded CHIPS R&D funding, develops the world’s most accurate commercial1 computers with industry-leading error correction fidelity.2  The company leverages established semiconductor manufacturing processes to help ensure reliability, repeatability, and scalability of the company’s current and future quantum computers.

“This award is a validation of Quantinuum’s leadership in trapped-ion quantum computing," said Dr. Rajeeb Hazra, President and CEO of Quantinuum. “Together with our domestic partners, we are building the technology and supply-chain foundation needed to scale fault-tolerant systems and strengthen America's leadership in this strategically important field.”        

The award will support R&D that the company expects to help strengthen and diversify its supply chain, adding onshore partners GlobalFoundries and Monarch Quantum. GlobalFoundries will be one of several of Quantinuum’s foundries enlisted to fabricate its next-generation ion traps and other electronics, specifically focused on using 300mm wafer technology; Monarch Quantum plans to develop and manufacture scalable, reliable lasers and optical components required for Quantinuum’s trapped-ion systems.

“As quantum computing moves closer to commercial scale, manufacturing will be critical to unlocking its full potential,” said Tim Breen, CEO of GlobalFoundries. “GlobalFoundries is proud to partner with Quantinuum to help scale their trapped-ion technology. By bringing our expertise in high-volume, differentiated semiconductor manufacturing, we're helping create a path to more scalable, reliable quantum hardware and advancing the next generation of American innovation.”

“The road to large-scale, trapped-ion quantum computers relies on moving away from complex, sprawling optical setups to scalable, reliable integrated photonics engines," said Dr. Timothy Day, CEO of Monarch Quantum. "We are honored to expand our partnership with Quantinuum to advance their hardware roadmap and to help strengthen U.S. leadership in quantum computing manufacturing and supply chain resilience.”

Together, these efforts are intended to reduce system complexity and improve component robustness, reliability, and reproducibility, ultimately supporting the continued scaling of trapped-ion quantum computers, while strengthening domestic capability across critical photonics and semiconductor manufacturing.

About Quantinuum

Quantinuum is a leading quantum computing company offering a full-stack platform designed to make quantum computing deployable in real-world environments. The company has commercially deployed multiple generations of trapped-ion based quantum systems built on the well-established QCCD architecture, which it has implemented with novel designs and capabilities to achieve the industry’s highest accuracy levels based on average two-qubit gate fidelity.3  Quantinuum has active engagements with market leaders across pharmaceuticals, material science, financial services, and government and industrial markets, as well as academic and research institutions globally. The company has a global workforce of over 800 employees, including top scientists and researchers. Quantinuum’s headquarters is in Broomfield, Colorado, with additional facilities across the United States, United Kingdom, Germany, Japan, Qatar, and Singapore. For more information, please visit www.quantinuum.com.

Cautionary Statement Concerning Forward-Looking Statements

This press release contains certain statements that may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts. The words “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “future,” “will,” “seek,” “foreseeable,” the negative version of these words, or similar terms and phrases are intended to identify forward-looking statements. Such statements are based on certain assumptions and assessments made by our management in light of their experience and their perception of historical trends, current economic and industry conditions, expected future developments and other factors they believe to be appropriate. The forward-looking statements included in this release are also subject to a number of material risks and uncertainties, including but not limited to economic, competitive, governmental, and technological factors affecting our operations, markets, products, services and prices. New factors emerge from time to time, and it is not possible for Quantinuum to predict all such factors. For additional information on these and other risks that could affect Quantinuum’s forward-looking statements, see Quantinuum’s risk factors discussed in its filings with the U.S. Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the period ended June 30, 2026, as such risk factors may be updated from time to time. Any forward-looking statement speaks only as of the date on which it is made, and, except as required by law, Quantinuum does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

1 Based on physical two-qubit gate fidelity as of December 31, 2025, according to the 2025 Ransford et al. study.
2 As of February 25, 2026, according to the 2026 Dasu et al. study.
3 As of December 31, 2025.

‍

This is some text inside of a div block.
All
This is some text inside of a div block.
All
This is some text inside of a div block.
All
September 4, 2026
Quantinuum to Participate in the Bernstein 23rd Annual Pan-European Strategic Decisions Conference

BROOMFIELD, Colo., September 4, 2026 - Quantinuum Inc. (Nasdaq: QNT) (the “Company”), a leading quantum computing company, today announced that members of its management team will participate in the Bernstein 23rd Annual Pan-European Strategic Decisions Conference, taking place September 9–10, 2026, in London, United Kingdom.

Quantinuum will participate in a fireside chat and host one-on-one meetings with investors during the conference.

About Quantinuum

Quantinuum is a leading quantum computing company offering a full-stack platform designed to make quantum computing deployable in real-world environments. The company has commercially deployed multiple generations of trapped-ion based quantum systems built on the well-established QCCD architecture, which it has implemented with novel designs and capabilities to achieve the industry’s highest accuracy levels based on average two-qubit gate fidelity. Quantinuum has active engagements with market leaders across pharmaceuticals, material science, financial services, and government and industrial markets, as well as academic and research institutions globally.

The company has a global workforce of approximately 800 employees, including top scientists and researchers. Over 70% of its technology team holds PhDs or Master’s degrees. Quantinuum’s headquarters is in Broomfield, Colorado, with additional facilities across the United States, United Kingdom, Germany, Japan, Qatar, and Singapore.

Contacts

Investor & Media Contact

Shub Mukherjee - Investor Contact - investors@quantinuum.com

Aaron Sorenson - Media Contact - press@quantinuum.com

‍

This is some text inside of a div block.
All
This is some text inside of a div block.
All
This is some text inside of a div block.
All